课题基金 / 基金详情

Production of useful tumor markers for gyvecologic tumors.

Production of useful tumor markers for gyvecologic tumors.
生产妇科肿瘤有用的肿瘤标志物。
批准号:
62480346
负责人:
INOUE Masaki
金额:
$4.42万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1987
资助国家:
日本
项目状态:
已结题
起止时间:
1987 至 1989

项目摘要

项目成果

INOUE Masaki的其他基金

相似基金

相关文献

中文摘要
翻译
制备了一种抗人子宫内膜腺癌细胞系的小鼠单克隆抗体MCA-97。在细胞酶联免疫特异性实验中,MCA-97抗体与所有腺癌细胞系反应,包括四种子宫内膜腺癌细胞系。估计MCA-97定义的抗原是一种非唾液化的高分子量糖蛋白,其行列式中含有半乳糖和n -乙酰氨基葡萄糖。在福尔马林固定、石蜡包埋切片的免疫过氧化物酶染色中,MCA-97与大多数子宫内膜腺癌和卵巢子宫内膜型腺癌反应,也与女性生殖器和胃肠道的正常腺上皮反应。然而,它在方状细胞癌和卵巢浆液性腺癌组织中大多无反应。通过反向被动血凝法,在三分之一的子宫内膜样腺癌患者和一半的卵巢子宫内膜腺癌患者的血清中检测到MCA-97定义的抗原。该抗原在大多数正常女性志愿者血清中不可见。因此,MCA-97在血清学和病理学诊断方面具有潜在的临床应用价值。
英文摘要
A murine monoclonal antibody ,MCA-97,was prepared against a human endometrial adenocarcinoma cell line. In cellular enzyme-linked immunospecific assay,the MCA-97 antibody reacted with all adenocarcinoma cell lines tested including four endometrial adenocarcinoma lines. The antigen defined by MCA-97 was estimated to be a non sialylated high-molecular-weight glycoprotein containing galactose and N-acetylglucosamine in its determinant. In immunoperoxidase staining of formalin-fixed, paraffin-embedded sections,MCA-97 reacted with most endometrial adenocarcinomas and ovarian endometrial-type adenocarcinomas, and also reacted with normal glandular epithelium of the female genital and gastrointestimal tracts. However, it was mostly unreactive with squarous cell carcinoma and ovarian serous adenocarcinoma tissues. By the reversed passive hemagglutination method, the antigen defined by MCA-97 was detected in the sera of one-third of patients with endometrioid adenocarcinomas, and in half of those with ovarian endometrial adenocarcinamas. The Antigen was not demonstrable in sera of most normal female volunteers. Thus, MCA-97 has potential clinical applications in diagnostic serology and pathology.
期刊论文(30)
专著(0)
科研奖励(0)
会议论文
Inoue M,Ogawa H Nakanishi K,et al: "Clinical value of sialyl Tn antiger in patients with gynecologic tumors." Obstet Gynecol(in press). 74. (1990)
Inoue M,Okawa H Nakanishi K,et al:“唾液酸 Tn 抗原在妇科肿瘤患者中的临床价值。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Inoue M,Nakayama M,Tanizawa O: "Altered expression of Lewis blood group and related antigens in fetal,normal adult and malignant tissues of the uterine endometrium" Virchows Archier A Pathological Anatomy and histopathology. 416. 221-228 (1990)
Inoue M,Nakayama M,Tanizawa O:“Lewis 血型和相关抗原在胎儿、正常成人和子宫内膜恶性组织中表达的改变” Virchows Archier A 病理解剖学和组织病理学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kimura T,Inoue M,Miyake A,et al: "The use of serum TA-4 in monitoring patients with malignant trausformation of ovarian mature cystic teratoma" Cancer. 64. 480-483 (1989)
Kimura T、Inoue M、Miyake A 等人:“血清 TA-4 在监测卵巢成熟囊性畸胎瘤恶性创伤患者中的应用”癌症。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 22 条
    Development of oncolytic virotherapy against the refractory gynecologic cancers
    • 批准号:
      21390450
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.32万
    • 财政年份:
      2009
    • 负责人:
      INOUE Masaki
    • 依托单位:
    Targeting the molecules useful for the diagnosis and treatment of endometrial cancers
    • 批准号:
      17390448
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.72万
    • 财政年份:
      2005
    • 负责人:
      INOUE Masaki
    • 依托单位:
    Detection of the hypennethylation of MLH1 promoter and its clinical application in endometrial cancer screening
    • 批准号:
      13557137
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $7.1万
    • 财政年份:
      2001
    • 负责人:
      INOUE Masaki
    • 依托单位:
    Gene therapy against ovarian cancers using hTERT promoter
    • 批准号:
      12470339
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.22万
    • 财政年份:
      2000
    • 负责人:
      INOUE Masaki
    • 依托单位:
    海外基金